These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32684538)

  • 1. Overhanging Bioresorbable Vascular Scaffold Observed on Angioscopy 1 Year After Implantation.
    Inoue H; Okamura A; Iwamoto M; Sumiyoshi A; Tanaka K; Takayasu K; Kawamura K; Koyama Y; Inoue K; Iwakura K; Fujii K; Sakata Y; Nagai H
    Circ J; 2020 Aug; 84(9):1605. PubMed ID: 32684538
    [No Abstract]   [Full Text] [Related]  

  • 2. Late neoatherosclerotic scaffold failure: An unexpected achilles heel for current bioresorbable scaffold technology?
    Hiltrop N; Jorge C; Bennett J; Adriaenssens T
    Int J Cardiol; 2016 Nov; 223():133-135. PubMed ID: 27537739
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioresorbable Vascular Scaffold Thrombosis: Clinical and Optical Coherence Tomography Findings.
    Cuesta J; García-Guimaraes M; Basante T; Rivero F; Antuña P; Alfonso F
    Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):90-91. PubMed ID: 29223378
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
    Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
    Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
    [No Abstract]   [Full Text] [Related]  

  • 5. Satisfactory arterial repair 1 year after ultrathin strut biodegradable polymer sirolimus-eluting stent implantation: an angioscopic observation.
    Ishihara T; Awata M; Iida O; Fujita M; Masuda M; Okamoto S; Nanto K; Kanda T; Tsujimura T; Uematsu M; Mano T
    Cardiovasc Interv Ther; 2019 Jan; 34(1):34-39. PubMed ID: 29335827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent Bioresorbable Vascular Scaffold by Optical Coherence Tomography Imaging at 5 Years.
    Moriyama N; Shishido K; Tobita K; Takada T; Ochiai T; Tsukuda S; Yamanaka F; Sugitatsu K; Mizuno S; Tanaka Y; Murakami M; Matsumi J; Takahashi S; Akasaka T; Saito S
    JACC Cardiovasc Interv; 2017 Jan; 10(2):e11-e13. PubMed ID: 28040440
    [No Abstract]   [Full Text] [Related]  

  • 7. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
    Danson E; Bhindi R; Hansen P
    Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
    [No Abstract]   [Full Text] [Related]  

  • 8. Restored Physiological Vasomotion Imitating Intrascaffold Restenosis 3 Years After Bioresorbable Scaffold Implantation.
    Ancona MB; Tanaka A; Latib A; Jabbour RJ; Kawamoto H; Regazzoli D; Mangieri A; Colombo A
    Can J Cardiol; 2016 Dec; 32(12):1574.e9-1574.e10. PubMed ID: 27211844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography.
    Attizzani GF; Ohno Y; Capranzano P; La Manna A; Francaviglia B; Grasso C; Sgroi C; Tamburino C; Longo G; Fujino Y; Capodanno D; Tamburino C
    Int J Cardiol; 2013 Dec; 170(2):e33-5. PubMed ID: 24210418
    [No Abstract]   [Full Text] [Related]  

  • 10. Different vascular healing process between bioabsorbable polymer-coated everolimus-eluting stents versus bioresorbable vascular scaffolds via optical coherence tomography and coronary angioscopy (the ENHANCE study: ENdothelial Healing Assessment with Novel Coronary tEchnology).
    Wan Ahmad WA; Nakayoshi T; Mahmood Zuhdi AS; Ismail MD; Zainal Abidin I; Ino Y; Kubo T; Akasaka T; Fukumoto Y; Ueno T
    Heart Vessels; 2020 Apr; 35(4):463-473. PubMed ID: 31587103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
    Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of post-dilatation on strut apposition of second-generation bioresorbable vascular scaffolds: Key role for scaffold thrombosis and prognosis?
    Frangieh AH; Jaguszewski M; Imori Y; Obeid S; Templin C
    Cardiol J; 2018; 25(1):148-150. PubMed ID: 29512102
    [No Abstract]   [Full Text] [Related]  

  • 13. Optical Coherence Tomography of Magnesium Bioresorbable Scaffold Restenosis.
    García-Blas S; Miñana G; Sanchis J
    Rev Esp Cardiol (Engl Ed); 2018 Dec; 71(12):1069. PubMed ID: 29223376
    [No Abstract]   [Full Text] [Related]  

  • 14. Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.
    Cassese S; Byrne RA; Ndrepepa G; Kufner S; Wiebe J; Repp J; Schunkert H; Fusaro M; Kimura T; Kastrati A
    Lancet; 2016 Feb; 387(10018):537-544. PubMed ID: 26597771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term intravascular follow-up of coronary bifurcation treatment with Absorb bioresorbable vascular scaffold.
    Vanhaverbeke M; McCutcheon K; Dubois C; Bennett J
    Acta Cardiol; 2018 Aug; 73(4):413-414. PubMed ID: 29277145
    [No Abstract]   [Full Text] [Related]  

  • 16. Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold.
    Koltowski L; Tomaniak M; Ochijewicz D; Zieliński K; Proniewska K; Malinowski KP; Zaleska M; Maksym J; Roleder T; Partyka L; Kochman W; Filipiak KJ; Opolski G; Kochman J
    Am J Cardiol; 2021 Sep; 155():23-31. PubMed ID: 34315572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procedural findings and early healing response after implantation of a self-apposing bioresorbable scaffold in coronary bifurcation lesions.
    Holck EN; Fox-Maule C; Barkholt TØ; Jakobsen L; Tu S; Maeng M; Dijkstra J; Christiansen EH; Holm NR
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1199-1210. PubMed ID: 31053981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry.
    La Manna A; Miccichè E; D'Agosta G; Tensol Rodrigues Pereira G; Attizzani GF; Capranzano P; Capodanno D; Tamburino C
    Int J Cardiol; 2018 Feb; 253():45-49. PubMed ID: 29137819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very Late Scaffold Thrombosis after Everolimus-Eluting Bioresorbable Scaffold Implantation in Patients with Unremarkable Interim Surveillance Angiography.
    Hoppmann P; Rai H; Colleran R; Kufner S; Wiebe J; Cassese S; Joner M; Laugwitz KL; Kastrati A; Byrne RA
    Cardiovasc Revasc Med; 2020 Mar; 21(3):361-366. PubMed ID: 31231028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late Self-Apposition With One-Year Persisting Uncoverage of Malapposed Bioresorbable Polymeric Struts.
    Francaviglia B; Capranzano P; Capodanno D; Barbanti M; Tamburino CI; Buccheri S; Tamburino C
    Can J Cardiol; 2017 Jul; 33(7):951.e5-951.e6. PubMed ID: 28579161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.